Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

Colorectal

CME

Colorectal Great Debate: Neoadjuvant Therapy for Locally Advanced Colon Cancer

Saturday, March 23, 2024
10:30am – 11:15am ET
Location:C102

    Moderator(s)

  • Mariam Eskander, MD, MPH

    Surgical Oncologist
    Rutgers Cancer Institute of New Jersey
    New Brunswick, New Jersey, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Mariam F. Eskander, MD, MPH: No financial relationships to disclose

The FOxTROT trial supports 6 weeks of neoadjuvant chemotherapy prior to the resection of operable, locally advanced colon cancer, but this issue remains controversial. Meanwhile, the nonrandomized NICHE trials reported high rates of pathologic response to neoadjuvant immunotherapy in patients with dMMR tumors. Presenters will discuss the data for and against the use of neoadjuvant chemotherapy and immunotherapy for locally advanced tumors.

Presentations:

  • 10:30am – 10:45am ET
    Pro

    Debater - Pro: Nader Hanna, MD (he/him/his) – Thomas Jefferson University

  • 10:45am – 11:00am ET
    Con

    Debater - Con: Sara W. Mayo, MD MS – Dartmouth College

  • 11:00am – 11:15am ET
    Questions & Answers